CSL News and Activities

Presence

CSL develops and supplies biopharmaceutical products, vaccines, and plasma therapies. It serves hospitals, healthcare providers, and patients with treatments for rare diseases, immune conditions, and influenza prevention.

CSL products and services overview:

Plasma therapies
Vaccines
Biopharmaceuticals
Iron deficiency treatments
Rare disease treatments
Influenza prevention

Revenue: ~$15 billion

Employees: 32,000

Headquarters: Melbourne, Australia

CSL is one of the...

CSL is a company listed under the stock ticker CSL (AU).

CSL has a direct presence in 10 countries.

CSL has 15 subsidiaries including CSL Behring, CSL Behring Austria and CSL Behring Denmark.

They are in:

Executives

View the org chart displaying its 110 main executives

Most searched biographies at CSL

Popular executive movements at CSL

Robin Cohen has joined the company as Vice President, Talent & Culture (posted on May 18 2026).
Roanne Parry, Chief Human Resources Officer, has left the company (posted on May 4 2026).
Amy Van Buren, who was Vice President, Human Resources, Global Operations and Plasma, is promoted to Chief People Officer (posted on April 13 2026).

Click here to view some more movements at CSL

Create your alert
to follow the executive moves at CSL.